Clinical Trial

A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors

Name: A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors — clinical trial record (NCT07351903)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GUARDIAN-02

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Trial Details

NCT Number	NCT07351903
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital Collaborators: Beijing Geekgene Technology Co., LTD
Conditions	Solid Tumors
Enrollment	15 participants
Start Date	2025-10-16
Primary Completion	2028-10-15 (estimated)
Study Completion	2029-02-14 (estimated)
Updated on ClinicalTrials.gov	2026-01-20